These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1360056)

  • 1. Adjuvant treatment with 5-fluorouracil for colorectal cancer.
    Hill GJ
    Lancet; 1992 Nov; 340(8831):1349-50. PubMed ID: 1360056
    [No Abstract]   [Full Text] [Related]  

  • 2. Mature results of adjuvant colon cancer trials from the fluorouracil-only era.
    Grem JL
    J Natl Cancer Inst; 2004 May; 96(10):727-9. PubMed ID: 15150295
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant chemotherapy of colorectal cancer.
    Cunningham D; Starling N
    Lancet; 2007 Dec; 370(9604):1980-1. PubMed ID: 18083386
    [No Abstract]   [Full Text] [Related]  

  • 4. In Vitro Adenosine Triphosphate-Based Chemotherapy Response Assay as a Predictor of Clinical Response to Fluorouracil-Based Adjuvant Chemotherapy in Stage II Colorectal Cancer.
    Kwon HY; Kim IK; Kang J; Sohn SK; Lee KY
    Cancer Res Treat; 2016 Jul; 48(3):970-7. PubMed ID: 26511802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy in colorectal cancer with high-dose leucovorin and fluorouracil: impact on disease-free survival and overall survival.
    Zaniboni A
    J Clin Oncol; 1997 Jun; 15(6):2432-41. PubMed ID: 9196159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy for colorectal cancer.
    Jankilevich G
    N Engl J Med; 2005 Apr; 352(17):1820-2; author reply 1820-2. PubMed ID: 15864822
    [No Abstract]   [Full Text] [Related]  

  • 7. Postoperative adjuvant chemotherapy is associated with a lower incidence of colorectal adenomas in patients with previous colorectal cancer.
    Lee HS; Kim SB; Lee HJ; Park SJ; Hong SP; Cheon JH; Kim WH; Kim TI
    Gastrointest Endosc; 2018 Mar; 87(3):688-694.e2. PubMed ID: 28431950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant therapy for resectable colorectal carcinoma with 5-fluorouracil portal vein infusion.
    Cremona F; Izzo F; Ruffolo F; Palaia R; Parisi V
    J Chemother; 1997 Apr; 9(2):140-1. PubMed ID: 9176762
    [No Abstract]   [Full Text] [Related]  

  • 9. [Gastrointestinal surgeons should master the adjuvant therapy of colorectal cancer].
    Gu J; Chen P
    Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Oct; 18(10):974-8. PubMed ID: 26499138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.
    Ribic CM; Sargent DJ; Moore MJ; Thibodeau SN; French AJ; Goldberg RM; Hamilton SR; Laurent-Puig P; Gryfe R; Shepherd LE; Tu D; Redston M; Gallinger S
    N Engl J Med; 2003 Jul; 349(3):247-57. PubMed ID: 12867608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of microsatellite instability for benefit from adjuvant fluorouracil chemotherapy in colorectal cancer.
    Iacopetta B; Watanabe T
    Gut; 2006 Nov; 55(11):1671-2. PubMed ID: 17047121
    [No Abstract]   [Full Text] [Related]  

  • 12. Predictive value of microsatellite instability for benefit from adjuvant fluorouracil chemotherapy in colorectal cancer.
    Jover R; Castells A; Llor X; Andreu M
    Gut; 2006 Dec; 55(12):1819-20. PubMed ID: 17124161
    [No Abstract]   [Full Text] [Related]  

  • 13. The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer.
    Crozier JE; McKee RF; McArdle CS; Angerson WJ; Anderson JH; Horgan PG; McMillan DC
    Br J Cancer; 2006 Jun; 94(12):1833-6. PubMed ID: 16721360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New possibilities in chemotherapy for colorectal cancer.
    Bekradda M; Cvitkovic E
    Ann Oncol; 1999; 10 Suppl 6():105-11. PubMed ID: 10676561
    [No Abstract]   [Full Text] [Related]  

  • 16. Lack of benefit of 5-fluorouracil-based adjuvant chemotherapy in colorectal cancer with microsatellite instability.
    Johnson L; Chu E
    Clin Colorectal Cancer; 2002 Nov; 2(3):146-8. PubMed ID: 12482330
    [No Abstract]   [Full Text] [Related]  

  • 17. Randomised controlled trial of adjuvant chemotherapy by portal-vein perfusion after curative resection for colorectal adenocarcinoma.
    Fielding LP; Hittinger R; Grace RH; Fry JS
    Lancet; 1992 Aug; 340(8818):502-6. PubMed ID: 1354275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On 5-fluorouracil therapy of colorectal cancer.
    Jensen SA
    Dan Med J; 2013 Jul; 60(7):B4603. PubMed ID: 23809976
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant chemotherapy for colorectal cancer.
    Rayter Z; Leicester RJ; Mansi JL
    Ann R Coll Surg Engl; 1995 Mar; 77(2):81-4. PubMed ID: 7793820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.